Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT00681551
First received: April 1, 2008
Last updated: December 11, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2004
  Estimated Primary Completion Date: No date given